http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101236188-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 |
| filingDate | 2011-03-10^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-02-22^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-02-22^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101236188-B1 |
| titleOfInvention | Novel Pyrrolopyridinone Derivatives and Their Therapeutic Uses for MCH Receptor-1 Related Diseases |
| abstract | The present invention is for preventing or treating a novel pyrrolopyridinone derivative represented by the following formula (1) or a pharmaceutically acceptable salt thereof, a preparation method thereof and MCH receptor-1 (melanin enriched hormone) -related diseases containing the same as an active ingredient In a pharmaceutical composition, the derivative according to the present invention acts as an antagonist to MCH receptor-1 and thus MCH receptor-1 such as obesity, diabetes, metabolic disorders, anxiety and depression caused by MCH binding to MCH receptor-1. It can be usefully used to prevent or treat related diseases. Formula 1 |
| priorityDate | 2011-03-10^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 389 of 389.